The company said that more than 800 people have been treated with Elevidys, with only one experiencing liver failure.

The trends on Gift Nifty also indicate a gap-up start for the Indian benchmark index. The Gift Nifty was trading around ...

Plenty of volatility awaits, but this market's potential growth is enormous thanks to cost-effective technological leaps.

Wondering where Apple stock may be in five years? Learn what the current state of AAPL stock is and what its five year ...

We recently published a list of Was Jim Cramer Right About These 16 Stocks?. In this article, we are going to take a look at ...

Donald Trump finally unveiled his first on-camera response Tuesday to a stock exchange rout that wiped billions from ...

Rigetti Computing (RGTI) is poised for growth in the quantum computing market with key milestones and a new Quanta Computer ...

Sarepta Therapeutics Inc.'s stock was down 21.6% in premarket trades on Tuesday after the commercial-stage biopharmaceutical company said a patient died from liver failure after using its drug ...

Steve Quirk, chief brokerage officer at Robinhood, said Sunday nights are now some of the busiest times on the platform for ...

making it one of the most expensive therapies in the U.S. Mizuho said the selling of the stock was likely an overreaction, noting that this is the first case of acute liver failure among patients ...

Over the years, multiple banks have come under regulatory scrutiny, dealt with financial setbacks, and triggered stock market ...